Simone Biles knew something wasn’t right. Warming up for the team gymnastics final at the Tokyo 2020 Olympic Games, the athlete known as the “G.O.A.T.” or “Greatest Of All Time”…
*This blog highlights key points discussed during Myriad Neuroscience’s March 1, 2022 webinar: “Are you playing offense or defense with your patients’ mental health? Enhancing your treatment playbook” The panel…
Making the most of your limited appointment time with patients is critical. That’s why we are introducing a new clinic collection kit for the GeneSight® test. “The GeneSight test provides…
Many people may incorrectly think ADHD, or attention-deficit/hyperactivity disorder, only impacts children. After all, according to the Centers for Disease Control and Prevention (CDC), “ADHD is one of the most…
Suicide loss can be overwhelming and feel isolating. Unfortunately, there are many people who understand what it’s like to lose someone they love to suicide, and how challenging it can…
With continued commitment to innovation, company makes updates to industry-leading PGx report SALT LAKE CITY, [March 13, 2022] –Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine,…
Information security and privacy is a critical part of the healthcare landscape for clinicians, patients, insurance companies, third party labs and beyond as they increasingly share private, protected information digitally.…
That feeling in the pit of your stomach. Worries that wake you at night. A heart that threatens to pound out of your chest. Are these feelings you face from…
Deadlines. Tests. Long lines at the grocery store. There’s no doubt that life is full of everyday stresses. In small doses, stress is vital to our wellbeing and can serve…
Anxiety disorders are the most common mental illness in the United States, affecting more than 40 million adults, according to the Anxiety and Depression Association of America (ADAA). But does…